CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-18 | Brownlie Keith L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2020-06-18 | MARINO JAMES J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2020-06-18 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2020-06-18 | Shoos Karen L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2020-06-18 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2020-06-11 | Young Diane C. SVP, Chief Medical Officer | Purchase | +2,115 | $4.73 | $10K | 2,115 |
| 2020-06-10 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Purchase | +1,050 | $4.83 | $5K | 1,367 |
| 2020-06-09 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Purchase | +1,000 | $3.01 | $3K | 1,000 |
| 2020-06-09 | Martin Samuel Bates SVP and CFO | Purchase | +9,750 | $3.05 | $30K | 10,735 |
| 2020-06-09 | MARINO JAMES J Director | Purchase | +8,305 | $3.00 | $25K | 12,704 |
| 2020-06-09 | KELER TIBOR Executive VP & CSO | Purchase | +5,000 | $2.99 | $15K | 7,357 |
| 2020-06-09 | Marucci Anthony S President & CEO | Purchase | +15,000 | $3.06 | $46K | 19,438 |
| 2019-07-08 | Young Diane C. SVP, Chief Medical Officer | Grant or award · Incentive Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2019-06-19 | PEPIN RONALD Sr. VP & CBO | Grant or award · Incentive Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2019-06-19 | Wright Richard M. Sr. VP & CCO | Grant or award · Incentive Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2019-06-19 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Grant or award · Incentive Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2019-06-19 | Crowley Elizabeth Sr. VP &CPDO | Grant or award · Incentive Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2019-06-19 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Grant or award · Incentive Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2019-06-19 | Martin Samuel Bates SVP and CFO | Grant or award · Incentive Stock Option (right to buy) | +43,000 | 43,000 | ||
| 2019-06-19 | KELER TIBOR Executive VP & CSO | Grant or award · Incentive Stock Option (right to buy) | +60,000 | 60,000 |
Page 15 of 17 · 325 trades